COVID-19 Surge Lifts Overall Molecular Point of Care Testing Market to $900 Million by Glenn S. Demby | Apr 3, 2021 | Articles, Earnings-lir, Essential, Laboratory Industry Report... This content is for Paid Members only.Login Register
FDA to SARS-CoV-2 Test Developers: Evaluate Impact of Genetic Mutations on Test Performance by Glenn S. Demby | Mar 23, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet, Testing Trends-dtet... This content is for Paid Members only.Login Register
FDA Clears the Way for Serial Use At-Home and Point-of-Care Asymptomatic Screening Tests by Glenn S. Demby | Mar 23, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet... This content is for Paid Members only.Login Register
Guardant Health Challenges Exact Sciences’ Leadership of Colorectal Cancer Diagnostics Market by Glenn S. Demby | Feb 26, 2021 | Articles, Essential, Industry Buzz-lir, Laboratory Industry Report... This content is for Paid Members only.Login Register
FDA Clears Neutralizing Antibodies Detection Test for COVID-19 by Glenn S. Demby | Feb 21, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet... This content is for Paid Members only.Login Register